RFK Jr.'s plan for changing the U.S. food and drug system
Robert F. Kennedy Jr., an environmental and anti-vaccine activist, was selected by President-elect Donald Trump to lead the ...
Snapshot of RFK Jr.'s plan for changing the U.S. food and drug system
RFK Jr., a prominent vaccine skeptic, wants to make many changes to the U.S. food and drug system as head of the HHS. Here's ...
FDA grants orphan drug designation to potential treatment of STXBP1 developmental and epileptic encephalopathy
Research that was carried out by Baylor College of Medicine and Texas Children's Hospital doctors has led to the U.S. Food ...
Factbox-RFK Jr.'s plan for changing the U.S. food and drug system
Kennedy has criticized the popular Novo Nordisk NOVOb.CO drug Ozempic, which is often prescribed for weight loss, saying it ...
MM&M3d
FDA rule on TV drug ads: compliance boon or comprehension bust?
Set to become compulsory Nov. 20, the regulation isn't likely to make pharma ads easier for consumers to comprehend, but ...
Pharmacies are yanking cold medicines from shelves. So what are the options now?
Feeling stuffy and ready to reach for NyQuil, Benadryl, or Sudafed PE? Not so fast. The Food and Drug Administration (FDA) has proposed ending the use of oral phenylephrine, a common ingredient found ...
Many Kids’ Melatonin Supplements Don’t Contain the Doses They Claim
A new study by F.D.A. scientists found that some products contained more than six times the amount on the label.
Comparing Oral vs. Injectable Semaglutide: Is One More Effective Than the Other?
It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...
New FDA rules for TV drug ads: Plain language and no distractions
The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...
News Medical2d
The benefits and challenges of FDA Fast-Track and Accelerated Approval in drug development
The FDA Modernization Act of 1997 established the Fast Track designation to expedite developing and reviewing new drugs ...